Urgent.News

600+ sources. One page. See who else covered it.

Editions

Health & Medicine

FDA Approves First CELMoD Drug for Multiple Myeloma

(MedPage Today) -- The FDA granted accelerated approval to the first cereblon E3 ligase modulation (CELMoD) therapy for relapsed or refractory multiple myeloma, the agency announced on Thursday. An oral drug, iberdomide (Zenbexus) is approved...

FDA Approves First CELMoD Drug for Multiple Myeloma

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Thursday 13 August →